This study is comparing closed-loop rTMS with Sham rTMS for people with depression. Participants receive closed-loop rTMS or Sham rTMS and complete study visits and assessments.

In United States

DepressionDeviceFrom 18 Years to 65 Years

Countries: United States
Sponsor: Stanford University
Condition: Depression

View study

CompletedNCT05772702

Closed-Loop Transcranial Alternating Current Stimulation for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 18 Years to 70 Years

Countries: United States
Sponsor: Electromedical Products International, Inc.
Condition: Depression

View study

CompletedNCT01123408

Clozapine and Olanzapine Treatment of Aggression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Schizophrenia

View study

CompletedNCT04325386

Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

Remote / online

SchizophreniaOtherFrom 22 Years to 85 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

View study

CompletedNCT01639872

Clozapine for Cannabis Use in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia

View study

CompletedNCT00029458

Clozapine for Treatment-Resistant Mania

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity

View study

TerminatedNCT00169039

Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 19 Years to 60 Years

Countries: United States
Sponsor: Harvard Medical School (HMS and HSDM)
Condition: Schizophrenia

View study

TerminatedNCT00169091

Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Harvard Medical School (HMS and HSDM)
Condition: Schizophrenia

View study

CompletedNCT00036582

Clozapine vs. Placebo in Treatment-Refractory Bipolarity in Children and Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrug

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Bipolarity

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.